Geode Capital Management, LLC Phio Pharmaceuticals Corp. Transaction History

Geode Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.33 - $63.51 $90 - $17,465	-275 Reduced 0.26%	106,917 $39,000
Q3 2021 Nov 12, 2021	BUY	$1.62 - $2.28 $31,899 - $44,895	19,691 Added 22.5%	107,192 $216,000
Q1 2021 May 12, 2021	BUY	$2.48 - $4.05 $166,611 - $272,087	67,182 Added 330.64%	87,501 $234,000
Q4 2020 Feb 12, 2021	BUY	$2.01 - $3.32 $40,841 - $67,459	20,319 New	20,319 $54,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $25M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.